HOUSE_OVERSIGHT_024916.jpg
1.15 MB
Extraction Summary
1
People
3
Organizations
3
Locations
1
Events
1
Relationships
2
Quotes
Document Information
Type:
Financial research report / disclaimer page
File Size:
1.15 MB
Summary
This document appears to be page 100 of a financial research report produced by Cowen Collaborative Insights, dated February 25, 2019. It details valuation methodologies and investment risks specifically related to the U.S. and Canadian cannabis industries. The page bears a House Oversight Committee Bates stamp, suggesting it was part of a larger production of documents, likely related to financial investigations, though the text itself does not mention Jeffrey Epstein.
People (1)
| Name | Role | Context |
|---|---|---|
| Michael Cella | Recipient/Employee |
Email address michael.cella@cowen.com appears in the watermark indicating the report is intended for him.
|
Organizations (3)
| Name | Type | Context |
|---|---|---|
| Cowen |
Author of the report (Cowen Collaborative Insights).
|
|
| Department of Treasury |
Mentioned regarding guidance on the Controlled Substances Act.
|
|
| House Oversight Committee |
Implied by the Bates stamp prefix 'HOUSE_OVERSIGHT'.
|
Timeline (1 events)
Locations (3)
| Location | Context |
|---|---|
|
Context of cannabis regulation.
|
|
|
Mentioned regarding legalization of cannabis activities.
|
|
|
Context of cannabis regulation and emerging industry.
|
Relationships (1)
Email address michael.cella@cowen.com in watermark.
Key Quotes (2)
"Our valuation methodology is primarily based on Relative EV-to-Sales (EV-to-Sales divided by Sales-Growth), followed by EV-to-Sales."Source
HOUSE_OVERSIGHT_024916.jpg
Quote #1
"The Department of Treasury has issued guidance that The Controlled Substances Act (“CSA”) makes it illegal under U.S. federal law to manufacture, distribute, or dispense cannabis and cannabis-related products."Source
HOUSE_OVERSIGHT_024916.jpg
Quote #2
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document